To investigate GLP-1's role in taste, the team used a strain of mice that were genetically engineered to lack GLP-1 receptors.
为了弄清glp - 1在味觉中的作用，该研究小组使用了一组通过基因改造而缺失glp - 1受体的老鼠。
To investigate GLP-1’s role in taste, the team used a strain of mice that were genetically engineered to lack GLP-1 receptors.
为了弄清GLP-1在味觉中的作用，该研究小组使用了一组通过基因改造而缺失GLP-1受体的老鼠。
Do they fit well with the newer drugs like GLP-1 analogues?
这类药物是否适合与像GLP - 1类似物这样的新型药物进行联合治疗？
For ISE measurements, an ionic strength constant value is stored with GLP data.
对于ISE测量，离子强度常数与GLP数据一同存储。
GLP-1m has insulinomimetic effects on hepatic glucose production and cardiac function.
GLP-1m对于肝脏糖合成及心脏功能有胰岛素拟态作用。
BYETTA is the first FDA-approved GLP-1 receptor agonist for the treatment of type 2 diabetes.
百泌达是FDA批准的治疗2型糖尿病的首个GLP- 1受体激动剂药物。
Conclusion GLP-2 can promote recovery of small intestinal epithelia from radiation injury in mice.
结论胰高血糖素样肽- 2可促进放射损伤小鼠肠上皮的恢复。
Patients with kidney failure should not be treated with GLP-1 because data from trials are not yet here.
由于目前尚没有试验数据，肾衰患者不应该使用GLP - 1治疗。
BYDUREON and BYETTA belong to the glucagon-like peptide-1 (GLP-1) receptor agonist class of medications.
BYDUREON和百泌达(BYETTA)都属于胰高血糖素样肽(GLP - 1)受体激动剂类药物。
On the other hand, drug technical evaluation will, also promote the implementation and improvement of GLP.
GLP有利于增进药品技术审评的科学化与规范化，而药品技术审评有助于促进GLP的实施与完善。
What makes it different is that it is based on the incretin hormone, GLP-1, which is secreted after a meal.
与众不同之处在于这类药物的作用机制是基于肠促胰岛素GLP-1的，GLP-1是在餐后分泌的。
With respect to renal impairment, overall we say that GLP-1 based therapy has the same indications as metformin.
肾功能损害方面，总体上讲，GLP - 1类药物与二甲双胍的适应症是相同的。
Thus, the function of GLP-1 is not limited to the islet cells, and it has regulatory actions on many other organs.
因此，GLP-1功能并不仅仅限于胰岛细胞，对于其他脏器同样有功能调节作用。
So lifestyle and GLP-1 interventions seem to actually be able to help patients keep their lifestyle to a better level.
因此生活方式干预和GLP-1治疗可能使患者的生活方式保持在一个更好的水平。
What we know is that there are GLP receptors spread throughout the body: in the heart, lung and central nervous system.
我们已经知道的是GLP受体遍布整个身体：在心脏，肺和中枢神经系统。
There are many challenges in developing an oral formulation of GLP-1, in particular obtaining adequate bioavailability.
开发口服型的GLP-1药物存在许多难题，尤其是需要有足够的生物利用度。
CONCLUSIONS -this study demonstrated that GLP-1 should be given continuously to obtain the most optimal glycemic control.
结论：本研究显示，GLP - 1应连续给药，以获得最优化的血糖控制。
International Diabetes: We have seen some research that suggests GLP-1 can improve endothelial function and heart function.
《国际糖尿病》：我们看到一些研究提示，GLP - 1可以改善内皮功能和心功能。
Main Outcome Measures: glucose, insulin, proinsulin, glucagon, GIP and GLP-1 levels were measured after 50 gr oral glucose.
主要观察指标：口服50gr葡萄糖以后检测葡萄糖、胰岛素、胰岛素原、胰高血糖素、抑胃肽和胰高血糖素样肽- 1的水平。
Objective It was a reference for GLP laboratory to develop standard operating procedures (SOP) of instruments and equipment.
目的为GLP实验室制定仪器设备的标准操作规程(SOP)提供参考。
This increase in GLP-1 secretion may be mediated via stimulation of sweet-taste receptors on L-cells by artificial sweetener.
GLP - 1分泌增加是通过人工甜味剂刺激L细胞上的甜味受体调节的。
CONCLUSIONS -monotherapy with GLP-1 and metformin have equal effects on plasma glucose and additive effects upon combination.
结论：GLP - 1和二甲双胍单药治疗对血糖效果相同，联合治疗会产生叠加效果。
PurposeTo investigate the effects of polysaccharide of Radix Glehniae (GLP) on nourishing Yin and regulating immune functions.
目的研究北沙参粗多糖(GLP)的滋阴和免疫调节作用。
The present invention can decrease production cost dramatically, also can produce GLP-1(7-36) and GLP-1 analogue in large scale.
本发明大大降低了生产成本，使得大规模生产GLP-1（7-36）及GLP-1类似物 成为可能。
Objective: To study the preventive actions of ganoderma lucidum polysaccharide (GLP) against kidney damage induced by cisplatin.
目的：研究灵芝多糖对顺铂肾毒性的预防作用。
GLP-1 has an effect with glucagon, which is part of its glucose lowering effect, but in a sense it is beyond the insulin effect.
GLP- 1可影响胰高血糖素的分泌，这是除影响胰岛素分泌外的另一降糖机制。
Objective To study the effects of GLP-2 on modulation of intestinal mucosa epithelium tight junction in obstructive jaundice rats.
目的探讨类高血糖素多肽- 2 (GLP - 2)对实验性梗阻性黄疸小肠上皮细胞紧密连接的调控。
Whether or not that is related to some direct effect on GLP-1 secretion is a hypothesis supported by some data in healthy subjects.
这是否与GLP - 1分泌的直接作用有关仍不清楚，一些来自健康受试者的数据支持这一假说。
CONCLUSION Geniposide has the similar function as the agonist for GLP-1 receptor, including neurotrophic and neuroprotective effects.
结论京尼平苷具有与GLP - 1受体激动剂类似的神经营养和神经保护功能。
CONCLUSIONS Weight reduction with GLP-1 receptor agonists was associated with a shift toward a more favorable cardiovascular risk profile.
结论：GLP - 1受体激动剂治疗后的体重减轻与心血管危险因素谱向更有益的方向转变有关。
应用推荐